8th Dec 2006 07:00
GlaxoSmithKline PLC07 December 2006 Issued - Thursday 7th December 2006 GLAXOSMITHKLINE PLC ANNOUNCES CHANGES TO BOARD COMMITTEES The Board has appointed Sir Christopher Gent a member of the RemunerationCommittee and Dr Dan Podolsky a member of the Audit Committee, both with effectfrom 1st January 2007. A table showing the membership of the Board and its committees with effect from1st January 2007 is attached. S M BicknellCompany Secretary7th December 2006 ________________________ BOARD AND COMMITTEE MEMBERSHIP WITH EFFECT FROM 1ST JANUARY 2007. Sir Christopher Gent Chairman Sir Ian Prosser Senior Independent Non-Executive Director Dr J-P Garnier Chief Executive Officer Mr Julian S Heslop Chief Financial Officer Dr Moncef Slaoui Executive Director, Chairman, Research & Development Mr H Larry Culp Independent Non-Executive Director Sir Crispin Davis Independent Non-Executive Director Sir Deryck Maughan Independent Non-Executive Director Dr Dan Podolsky Independent Non-Executive Director Dr Ronaldo Schmitz Independent Non-Executive Director Mr Tom De Swaan Independent Non Executive Director Sir Robert Wilson Independent Non-Executive Director Board Committee Committee Chairman Members Audit Mr Tom De Swaan Sir Deryck Maughan Dr Dan Podolsky Sir Ian Prosser Dr Ronaldo Schmitz Sir Robert Wilson Remuneration Sir Robert Wilson Mr H Lawrence Culp Sir Crispin Davis Sir Christopher Gent Dr Ronaldo Schmitz Nominations Sir Christopher Gent Sir Ian Prosser Dr Ronaldo Schmitz Corporate Responsibility Sir Christopher Gent Sir Ian Prosser Dr Dan Podolsky Mr Tom de Swaan This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline